Skip to content

Hold

DRUG2 trials

Sponsors

University of Nottingham, Maastricht University Medical Center

Conditions

AnticoagulantsHematologic NeoplasmsHypertensionPerioperative HypertensionPlatelet Aggregation InhibitorsThrombocytopenia